Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02212561
Title Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute leukemia

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Selinexor

Cytarabine

Cytarabine + Dexamethasone + Methotrexate

Fludarabine

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Phoenix Children's Hospital Phoenix Arizona 85016 United States Details
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
St. Jude Children's Research Hospital Memphis Tennessee 38105 United States Details
Cook Children's Medical Center Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field